These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10121675)

  • 1. Biotechnology: will it break the health care bank?
    McGivney WT
    Physician Exec; 1992; 18(5):35-6. PubMed ID: 10121675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biotechnology drugs create new maze of concerns for hospitals.
    Lumsdon K
    Hospitals; 1991 Dec; 65(23):32, 34-5. PubMed ID: 1937456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Projecting future drug expenditures--1994.
    Santell JP
    Am J Hosp Pharm; 1994 Jan; 51(2):177-87. PubMed ID: 8160668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specifications from a biotechnology industry perspective.
    Garnick RL
    Dev Biol Stand; 1997; 91():31-6. PubMed ID: 9413680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacoeconomics of high-cost biotechnology products.
    Dana WJ; Farthing K
    Pharm Pract Manag Q; 1998 Jul; 18(2):23-31. PubMed ID: 10185236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multisource drugs: implications and concerns in the geriatric population.
    Gerbino PP; Joseph AS
    Hosp Pharm; 1993 Feb; 28(2):96-8, 101-2. PubMed ID: 10125706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Projecting future drug expenditures--1992.
    Ensor PA
    Am J Hosp Pharm; 1992 Jan; 49(1):140-5. PubMed ID: 1570858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutraceuticals: poised for a healthy slice of the healthcare market?
    Brower V
    Nat Biotechnol; 1998 Aug; 16(8):728-31. PubMed ID: 9702769
    [No Abstract]   [Full Text] [Related]  

  • 9. The changing environment for technological innovation in health care.
    Goodman CS; Gelijns AC
    Baxter Health Policy Rev; 1996; 2():267-315. PubMed ID: 11066263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biopharmaceutical payment and coverage: are cost control policies too restrictive? Industrial Biotechnology Association.
    Healthspan; 1990 Jun; 7(6):6-9. PubMed ID: 10105178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sandoz sues FDA over delay in first biogeneric approval.
    Fox JL
    Nat Biotechnol; 2005 Nov; 23(11):1327-8. PubMed ID: 16273046
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmaceutical industry.
    Lewis L
    State Health Care Am; 1994; ():23-7. PubMed ID: 10133845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rising costs hold up drug discovery.
    Miller HI
    Nature; 1998 Oct; 395(6705):835. PubMed ID: 9804407
    [No Abstract]   [Full Text] [Related]  

  • 14. When is a cost-effectiveness claim valid? How much should the FDA care?
    Luce BR; Hillman AL
    Am J Manag Care; 1997 Nov; 3(11):1660-6. PubMed ID: 10178464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CBER status on reform initiatives: industry reactions and comments.
    Page M
    Food Drug Law J; 1997; 52(2):193-6. PubMed ID: 10557559
    [No Abstract]   [Full Text] [Related]  

  • 16. Biotech drugs: high costs becoming hard to swallow.
    Wagner M
    Mod Healthc; 1992 Jan; 22(2):24-5, 28-9. PubMed ID: 10115803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National drug bill to continue rising by 14%-18%.
    Manag Care; 2003 Jul; 12(7):52. PubMed ID: 12891957
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA launches priority vouchers for neglected-disease drugs.
    Waltz E
    Nat Biotechnol; 2008 Dec; 26(12):1315-6. PubMed ID: 19060849
    [No Abstract]   [Full Text] [Related]  

  • 19. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical provisions of the FDA Modernization Act of 1997: one year and counting.
    Binder GM
    Curr Opin Biotechnol; 1999 Jun; 10(3):303-6. PubMed ID: 10361077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.